Burkholderia pseudomallei kills the nematode Caenorhabditis elegans using an endotoxin-mediated paralysis

Cellular Microbiology

Volumn 3, Issue 6, 2001, Pages 381-393

  O'Quinn, A L ^a   Wiegand, E M ^a   Jeddeloh, J A ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BACTERIAL ENZYME; BACTERIUM LIPOPOLYSACCHARIDE; CALCIUM ION; ENDOTOXIN; MACROLIDE; O ANTIGEN; VIRULENCE FACTOR;

ANIMAL; ARTICLE; ATTENUATION; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BIOLOGICAL WARFARE; BURKHOLDERIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; BURKHOLDERIA THAILANDENSIS; CAENORHABDITIS ELEGANS; CELL MOTILITY; DIFFUSION; DISEASE MODEL; DRUG TRANSPORT; ENZYME RELEASE; GAMMA IRRADIATION; GENETIC SCREENING; MUTATION; NEMATODE; NONHUMAN; PARALYSIS; PATHOGENICITY; PRIORITY JOURNAL; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; SPECIES; SYMPTOM; ULTRAVIOLET RADIATION; VERTEBRATE;

ANIMALS; BACTERIAL TOXINS; BIOLOGICAL WARFARE; BURKHOLDERIA; BURKHOLDERIA PSEUDOMALLEI; CAENORHABDITIS ELEGANS; ENDOTOXINS; MUTATION; PARALYSIS;

ANIMALIA; BACTERIA (MICROORGANISMS); BURKHOLDERIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; BURKHOLDERIA THAILANDENSIS; CAENORHABDITIS ELEGANS; MAMMALIA; NEMATODA; VERTEBRATA;

EID: 0034960639     PISSN: 14625814     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1462-5822.2001.00118.x     Document Type: Article

References (44)

1. Biohazard
2. Melioidosis - A disease for all organs
3. Effects of starvation and neuroactive drugs on feeding in Caenorhabditis elegans
4. Characterization of Burkholderia pseudomallei and Burkholderia pseudomallei-like strains
5. Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species
6. Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei
7. Melioidosis
8. Lethal paralysis of Caenorhabditis elegans by Pseudomonas aeruginosa
9. The genetics of ivermectin resistance in Caenorhabditis elegans
10. Mutagenesis of Burkholderia pseudomallei with Tn5-OT182: Isolation of motility mutants and molecular characterization of the flagellin structural gene
11. The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence
12. Molecular characterization of genetic loci required for secretion of exoproducts in Burkholderia pseudomallei
13. Chemotaxis defective mutants of C. elegans
14. The hamster model of intraperitoneal Burkholderia mallei
15. Toxin production by Burkholderia pseudomallei strains and correlation with severity of melioidosis
16. Four genes from Pseudomonas fluorescens that encode the biosynthesis of pyrrolnitrin
17. Conservation of the pyrrolnitrin biosynthetic gene cluster among six pyrrolnitrin producing strains
18. Effects of Burkholderia pseudomallei and other Burkholderia species on eukaryotic cells in tissue culture
19. Purification and characterization of a cytotoxic exolipid of Burkholderia pseudomallei
20. Normal and mutant thermotaxis in the nematode Caenorhabditis elegans
21. Feeding is inhibited by sublethal concentrations of toxicants and by heat stress in the nematode Caenorhabditis elegans: Relationship to the cellular stress response
22. Man-to-man transmission of melioidosis
23. Mutations in the alpha1 subunit of an L-type voltage-activated Ca2+ channel cause myotonia in Caenorhabditis elegans
24. Arabinose positive Burkholderia pseudomallei infection in humans: Case-report
25. Human-to-human transmission of Pseudomonas pseudomallei
26. Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa-Caenorhabditis elegans pathogenesis model
27. Genetic organization in C. elegans: Fine structure analysis of the unc-22 gene
28. Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei
29. Pathological changes in goats experimentally inoculated with Pseudomonas pseudomallei
30. Human glanders
31. Toxin production by Malleomyces pseudomallei
32. 22-Hydroxy derivatives of C-076 compounds, pharmaceutical compositions and method of use
33. Common virulence factors for bacterial pathogenicity in plants and animals
34. CaMKII regulates the density of central glutamatergic synapses in vivo
35. A calcium-channel homologue required for adaptation to dopamine and serotonin in Caenorhabditis elegans
36. Arabinose assimilation defines a nonvirulent biotype of Burkholderia pseudomallei
37. Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis
38. Pseudomonas aeruginosa killing of Caenorhabditis elegans used to identify P. aeruginosa virulence factors
39. Alpha-haemolysin of uropathogenic E. coli induces Ca2+ oscillations in renal epithelial cells
40. The behavioral genetics of Caenorhabditis elegans
41. Current studies on the pathogenesis of melioidosis
42. Neurological melioidosis: Seven cases from the Northern Territory of Australia
43. Burkholderia pseudomallei and melioidosis: Be aware in temperate area